| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/07/2006 | US6994987 Process for producing tripeptides |
| 02/07/2006 | US6994970 Peptides which bind auto-antibodies for use in extracorporeal treatment; peptides bound to solid support for chromatography; specified amino acid sequence |
| 02/07/2006 | US6994957 Using nucleic acid |
| 02/07/2006 | US6994863 Pharmaceutical and cosmetic carrier and composition for topical application |
| 02/07/2006 | US6994859 Biologically active, hemagglutinin from type A Clostridium botulinum and methods of use |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | CA2375040C Orally active a1 adenosine receptor agonists |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/07/2006 | CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha. |
| 02/02/2006 | WO2006012473A1 Dynamic knowledge-based networking system and method |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | WO2005105789A3 Novel pyrrole derivatives with angiotensin ii antagonist activity |
| 02/02/2006 | WO2004103286A3 Compositions of a cyclooxygenase-2 selective inhibitor and a cholimergic agent |
| 02/02/2006 | US20060025597 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 02/02/2006 | US20060025590 Novel compounds |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025464 Benzimidazole derivatives as therapeutic agents |
| 02/02/2006 | US20060025461 Triazole derivative |
| 02/02/2006 | US20060025452 Method of treating demyelinating diseases or conditions |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025396 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 02/02/2006 | US20060025386 Method of treatment of retinal ischemia with diazoxide |
| 02/02/2006 | US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 02/02/2006 | US20060025352 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 02/02/2006 | US20060025344 Ghrelin receptor inverse agonists for regulation of feeding behaviors |
| 02/02/2006 | US20060025343 Angiogenically effective unit dose fo FGF and method of adminstering |
| 02/02/2006 | US20060025334 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 02/02/2006 | US20060025333 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024727 Antisense modulation of C-reactive protein expression |
| 02/02/2006 | US20060024664 Characterizing purity and activity of polysaccharide preparations including glycosaminoglycans such as heparin |
| 02/02/2006 | US20060024334 Immunotherapeutic methods and systems |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024234 Protein markers for pharmaceuticals and related toxicity |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | DE102004034623A1 Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 6-formyl-tetrahydropteridines, processes for their preparation and their use as medicaments |
| 02/02/2006 | DE102004033834A1 New 1-sulfonyl-2-oxo-dihydroindole derivatives are selective antagonists of vasopressin receptors useful e.g. for treating hypertension, cardiac insufficiency, unstable angina or affective disorders |
| 02/02/2006 | CA2575272A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 02/02/2006 | CA2575254A1 Preparation of hydrochloride salts of tetrazole derivative |
| 02/02/2006 | CA2570688A1 Compounds and methods for treating dyslipidemia |
| 02/01/2006 | EP1621548A2 Polypeptides, CDNAs encoding the same and utilization thereof |
| 02/01/2006 | EP1621544A1 Remedies for diseases caused by strengthened vascular smooth muscle using 14-membered ring macrolide compounds |
| 02/01/2006 | EP1621540A1 Nitrogen-containing heterocyclic compounds and use thereof |
| 02/01/2006 | EP1621537A1 Five-membered heterocyclic derivative |
| 02/01/2006 | EP1621210A1 Adiponectin production enhancer |
| 02/01/2006 | EP1621201A1 Hesperidin for prophylaxis and treatment of diseases of the central nervous system, in particular Alzheimer's and Parkinson's diseases, for therapy after stroke as well as for chronic pain. |
| 02/01/2006 | EP1620409A1 Quinoxalin-3-one derivatives as orexin receptor antagonists |
| 02/01/2006 | EP1620132A1 Biological pacemaker |
| 02/01/2006 | EP1620125A2 Tolerance to graft following thymic reactivation |
| 02/01/2006 | EP1620123A2 Genetic modification of targeted regions of the cardiac conduction system |
| 02/01/2006 | EP1620116A2 Use of quinquina for the preparation of a medicament stimulating angiogenesis |
| 02/01/2006 | EP1620104A1 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 02/01/2006 | EP1620097A1 Prophylactic pretreatment with antioxidants |
| 02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
| 02/01/2006 | EP1619962A1 Composition for oral administration containing capsaicinoids |
| 02/01/2006 | EP1619952A2 Tolerance to graft prior to thymic regeneration |
| 02/01/2006 | EP1509202A4 Novel high viscosity embolizing compositions comprising prepolymers |
| 02/01/2006 | EP1500654B1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 02/01/2006 | EP1466622A4 Medicinal agent and method for curing diseases accompanied with vascular dystonia |
| 02/01/2006 | EP1430144A4 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 02/01/2006 | EP1425281B1 Tricyclic CRF receptor antagonists |
| 02/01/2006 | EP1370548B1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same |
| 02/01/2006 | EP1328266B1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 02/01/2006 | EP1268502B1 O-aryl glucoside sglt2 inhibitors and method |
| 02/01/2006 | EP1254121B1 Preparation of sulfonamides |
| 02/01/2006 | EP1235812B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/01/2006 | EP1223953B1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 02/01/2006 | EP1169336B1 Ent-steroids as selectively active estrogens |
| 02/01/2006 | EP1146894B1 Uses of thank protein, a tnf homologue, to inhibit growth of tumour cells |
| 02/01/2006 | EP1131302B1 Substituted 4-amino-2-aryl-cyclopenta [d]pyrimidines, their production and use and pharmaceutical preparations containing the same |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | EP0759297B1 Remedy for pulmonary heart |
| 02/01/2006 | CN1728989A Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta. |
| 02/01/2006 | CN1727358A Steroid saponin of alpha, beta double bond structure outside furan nucleus, preparation method and application |
| 02/01/2006 | CN1726977A Vegetable complex liquid for heart resurrection |
| 02/01/2006 | CN1726975A Chinese traditional medicine for treating coronar yheart disease an high blood pressure |
| 02/01/2006 | CN1726966A Preparation of oral disintegration tablet in use for treating disease of apoplexy and obstruction of qi in the chest |
| 02/01/2006 | CN1726965A Method for preparing extract product of paeoniflorin |
| 02/01/2006 | CN1726959A Method of preparing medication for treating cardiovascular diseases, and method for controlling quality |
| 02/01/2006 | CN1726957A Freeze drying powder and injection preparation in use for invigorating pulse-beat, and preparation method |
| 02/01/2006 | CN1726956A Extract product of general flavone of kudzuvine root, preparation method and application |
| 02/01/2006 | CN1726946A Freeze-drying powder and injection preparation for stretching thoracic part, and preparation method |
| 02/01/2006 | CN1726945A Solid dispersion of extractive of general flavone of Balsamiferou Blumea Herb |
| 02/01/2006 | CN1726942A Quick thrombolysis for apoplexy |
| 02/01/2006 | CN1726941A Medicine for treating chronic hemorrhoids |
| 02/01/2006 | CN1726931A Method for preparing medication of gastrodia tuber and tuber of multiflower knotweed |
| 02/01/2006 | CN1726924A Combination of medication of possessing synergistic reaction |
| 02/01/2006 | CN1726923A Combination of medication for treating cardiovascular diseases and cerebrovascular disease |
| 02/01/2006 | CN1726921A Oral preparation of prostaglandin E1 |
| 02/01/2006 | CN1726920A Nose taking powder of prostaglandin E |
| 02/01/2006 | CN1726915A Nasal cavity taken drug system and combination of naloxone hydrochloride and preparation method |
| 02/01/2006 | CN1726909A Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application |
| 02/01/2006 | CN1726906A Slowl released tablet of naftifurine oxalate and producing method |
| 02/01/2006 | CN1726905A Isosorbide mononitrate capsule and dry preparation method |